Later, the same group demonstrated that tamoxifen sensitizes leukemia cells (T-ALL) to CBD (30 μM), promoting synergism and leading to a significant increase in apoptosis (p < 0.0001), with the release of cytochrome c and mitochondrial dysfunction [53]. This evidence concerns the gene CYCS and leukemia.